#HVO hVIVO PLC – Annual Report & Notice of AGM April 17, 2026 – Posted in: hVIVO (HVO)

London, UK – 17 April 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, confirms that the Company’s Annual Report and Accounts for the year ended 31 December 2025 and the Notice of Annual General Meeting (“AGM”) will be posted to shareholders today. The 2025 Annual Report and Accounts, the Notice of AGM and accompanying form of proxy are available to download from the Company’s website: www.hvivo.com. …

#VELA investee co. #CSFS Cornerstone FS – Final Results, Annual Report & AGM Notice May 8, 2024 – Posted in: Vela Technologies Plc (VELA)

Cornerstone FS plc (AIM: CSFS) (trading as Finseta), a foreign exchange and payments solutions company offering multi-currency accounts to businesses and individuals through its proprietary technology platform, is pleased to announce its audited final results for the year ended 31 December 2023. In addition, the Company gives notices of its annual general meeting (“AGM”) and the publication of its annual report and accounts. Financial Highlights · Revenue increased 100% to £9.6m (2022: £4.8m) · …

#VELA investee co. #CSFS Cornerstone FS PLC – 2023 Full Year Trading Update January 10, 2024 – Posted in: Vela Technologies Plc (VELA)

Cornerstone FS plc (AIM: CSFS), a foreign exchange and payments solutions company offering multi-currency accounts to businesses and individuals through its proprietary technology platform, is pleased to provide an update on trading for the year ended 31 December 2023. The information contained herein has not been audited and may be subject to further review and amendment. Highlights · Revenue growth of 100% to c. £9.6m (2022: £4.8m) · Gross margin improvement to c. 63%…

#TSP TruSpine Technologies PLC – Half-year Report December 28, 2023 – Posted in: Blog, TruSpine Plc (TSP)

CHIEF EXECUTIVE’S REPORT During the period under review and the period to date the Company is pleased to have made progress on three fronts namely :- – the FDA submission is progressing and has now reached the substantive phase which it is currently undergoing and the Company is hoping for more positive news in the New Year. – Following the registration of its IP title, the Company anticipates signing a distribution agreement in 2024. – …

#HVO hVIVO PLC – Annual Report and Notice of AGM April 28, 2023 – Posted in: hVIVO (HVO)

hVIVO plc (AIM & Euronext: HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, confirms that the Company’s Annual Report and Accounts for the year ended 31 December 2022 and the Notice of Annual General Meeting (“AGM”) will be posted to shareholders today. The 2022 Annual Report and Accounts, the Notice of AGM and accompanying form…

#VELA Vela Technologies Plc Investee – Cornerstone – Variation of Incentivisation & Settlement Arr. March 8, 2023 – Posted in: Vela Technologies Plc (VELA)

Cornerstone FS Plc (AIM: CSFS), a foreign exchange and payments company offering multi-currency accounts to businesses and individuals, announces that it has agreed to vary certain incentivisation and settlement arrangements with Robert O’Brien, General Manager APAC and Middle East, and Craig Strong, Director of Capital Currencies Ltd (“Capital Currencies”), a wholly-owned subsidiary of the Company that was acquired on 31 January 2022. The repayment date of Mr. O’Brien’s £2m loan note, which was issued…

#VELA Vela Technologies PLC – Quarterly Investment Update February 10, 2023 – Posted in: Vela Technologies Plc (VELA)

The Board of Vela (AIM:VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, is pleased to report an update for the quarter ended 31 December 2022. Executive Director, James Normand, commented: “I am pleased to report that Vela’s gross asset value increased by 8.3% during the quarter ended 31 December 2022. This was largely attributable to a rise in the quoted price for EnSilica’s shares in this period, which we believe…

#ORPH Open Orphan – Board appointment and Annual Report and Notice of AGM June 10, 2022 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials , announces the appointment of Martin Gouldstone as an Independent Non-Executive Director of the Company with effect from 8 June 2022. Martin will also Chair the Audit & Risk Committee and will be a member of the Nominations Committee and the Remuneration Committee. ORPH also confirms that the Company’s Annual…

VELA TECHNOLOGIES #VELA INVESTEE COMPANY – KANABO GROUP #KNB – Final Results June 6, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

Kanabo Group Plc (LON: KNB), a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, is pleased to announce its Full Year Audited Results for the year ended 31 December 2021. Period Highlights Successful listing of the Company’s shares on 16 February 2021 to become one of the first medical cannabis companies on the London Stock Exchange, raising gross proceeds of £6 million…